BioAssay Works is excited to announce our participation at ADLM 2025 Clinical Lab Expo on July 29-31 in Chicago! Visit us in Booth #1937. (more…)

BioAssay Works LLC (BAW), a leading developer and manufacturer of lateral flow assays and reagents, is pleased to announce the appointment of Dr. Doğuş Işık and Dr. Olivier Côté as its new Chief Executive Officers. Doğuş brings extensive experience in scalable nanotechnology solutions to the role, with a proven track (more…)

BioAssay Works LLC (BAW) announces the retirement of Stephen Mefferd, BAW’s co-founder and President.   During the past 20 years at BAW, Stephen has been instrumental in leading the company from a startup to a leading developer and manufacturer of lateral flow assays and reagents. Prior to founding BAW, Stephen worked (more…)

BioAssay Works (BAW) further enhanced their assay development and manufacturing services capabilities by adding 1,000 square feet of R&D and manufacturing space. In addition, BAW acquired a new reel-to-reel membrane and gold conjugate ribbon striping machine. “The additional space and new equipment expands our manufacturing capacity significantly”, noted Vice President (more…)